Difficulty: Medium
Average Score: 80%
Practice
Which of the following anxiolytics has minimal abuse liability?
Correct answer
B
Rationale
In the context of lifespan pharmacology, understanding the abuse liability of anxiolytics is crucial for safe and effective prescribing practices. The correct answer is option B) Buspirone, which has minimal abuse liability compared to the other options.
Buspirone is a non-benzodiazepine anxiolytic that acts on serotonin receptors, specifically the 5-HT1A receptor. Unlike benzodiazepines like Oxazepam (Option A) and Alprazolam (Option D), buspirone does not target the gamma-aminobutyric acid (GABA) system, which is associated with the sedative and addictive properties of benzodiazepines. Therefore, buspirone is less likely to be abused due to its unique mechanism of action.
Flumazenil (Option C) is a benzodiazepine antagonist used to reverse the effects of benzodiazepine overdose and is not an anxiolytic itself. It does not possess abuse liability.
Educationally, this question highlights the importance of selecting appropriate anxiolytics based on their pharmacological properties to minimize the risk of abuse and dependence. Understanding the differences in mechanisms of action among anxiolytics allows healthcare providers to make informed decisions when treating patients with anxiety disorders across the lifespan.
Buspirone is a non-benzodiazepine anxiolytic that acts on serotonin receptors, specifically the 5-HT1A receptor. Unlike benzodiazepines like Oxazepam (Option A) and Alprazolam (Option D), buspirone does not target the gamma-aminobutyric acid (GABA) system, which is associated with the sedative and addictive properties of benzodiazepines. Therefore, buspirone is less likely to be abused due to its unique mechanism of action.
Flumazenil (Option C) is a benzodiazepine antagonist used to reverse the effects of benzodiazepine overdose and is not an anxiolytic itself. It does not possess abuse liability.
Educationally, this question highlights the importance of selecting appropriate anxiolytics based on their pharmacological properties to minimize the risk of abuse and dependence. Understanding the differences in mechanisms of action among anxiolytics allows healthcare providers to make informed decisions when treating patients with anxiety disorders across the lifespan.